APMD: Apnimed, Inc.
Performance
APMD -36.76%
Watchlist
Select an item
Summary
APMD at a glance
APMD returned -36.76% since Jul 31, 2026. Its worst drop since then was -56.50%, smaller than 16% of stocks on Redstone, and its Sharpe ratio of -1.41 beats 1% of stocks on Redstone. It hasn't paid a dividend since it listed.
Current Drawdown
-51.43%
Rolling Volatility
81.29%
Actions
Metrics
Risk Indicators*
Alpha-128.20%
Beta1.52x
Sharpe-1.41
Sortino-1.79
Omega0.80
Calmar-0.65
Martin-4.04
Profile
About APMD
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $658M
- Listed
- Jul 2026
- Headquarters
- Cambridge, MA
- Website
- apnimed.com
Comparisons